The following individuals should be screened for Candida auris:
Anyone who, over the four weeks prior to specimen collection, shared a room with an individual identified with C. auris infection or colonization, regardless of the use of contact precautions or length of stay.
All patients in the same healthcare area that overlap in healthcare stay with an individual identified with C. auris infection or colonization, regardless of the use of contact precautions.
Patients currently occupying a room that previously housed an individual identified with C. auris.
Individuals with current multidrug-resistant gram negative bacteria that received healthcare outside of the US within the last 12 months.
Patients transferring from a unit or facility with current transmission of C. auris or recent transmission within the last 30 days.
Notes:
Facilities should consider adding C. auris to existing multidrug-resistant organism (MDRO) screening protocols, via a composite swab of the patient’s bilateral axilla and groin. For guidance on performing swab testing in-house, refer to: https://www.cdc.gov/fungal/candida-auris/c-auris-guidance.html.
All ages are at risk for C. auris infections.
Routine screening of healthcare workers and the environment are not recommended unless epidemiological evidence links to transmission or where transmission persists despite other interventions.